During the past decade, Michael Washburn Center for Ophthalmic Research LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Michael Washburn Center for Ophthalmic Research LLC" are "Blepharitis" (1 trials) and "Dry Eye Disease" (1 trials). Many other conditions were trialed in "Michael Washburn Center for Ophthalmic Research LLC" in a lesser frequency.

Most popular intervention types in "Michael Washburn Center for Ophthalmic Research LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AR 15512 Ophthalmic Solution" (1 trials), "TP-03" (1 trials), "TP-03 Vehicle" (1 trials) and "Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michael Washburn Center for Ophthalmic Research LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Michael Washburn Center for Ophthalmic Research LLC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Michael Washburn Center for Ophthalmic Research LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michael Washburn Center for Ophthalmic Research LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".